There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Agios Pharma (NASDAQ:AGIO) and Tactile Systems Technology (NASDAQ:TCMD) with bullish sentiments.
Agios Pharma (AGIO)
In a report released today, John Newman from Canaccord Genuity maintained a Buy rating on Agios Pharma, with a price target of $90. The company’s shares opened today at $82.38.
Newman observed:
“We maintain a favorable view on Fouse as the CEO given her expensive experience at Laboratories, holding various senior roles focusing on corporate strategies, finance, and operations. We believe Fouse will help maintain AGIO’s heading in launching the approved products and developing the pipeline.”
According to TipRanks.com, Newman is a 5-star analyst with an average return of 18.3% and a 48.8% success rate. Newman covers the Healthcare sector, focusing on stocks such as Hutchison China MediTech Ltd, Atara Biotherapeutics, and Gemphire Therapeutics.
Agios Pharma has an analyst consensus of Strong Buy, with a price target consensus of $106.75.
See today’s analyst top recommended stocks >>
Tactile Systems Technology (TCMD)
In a report released today, Jason Mills from Canaccord Genuity maintained a Buy rating on Tactile Systems Technology, with a price target of $75. The company’s shares opened today at $68.18, close to its 52-week high of $70.15.
Mills said:
“We continue to see a long runway for strong ~20% growth via further penetration of a large and vastly underpenetrated moderate/severe lymphedema patient population in the US, further augmented over the longer term by the head & neck indication. We reiterate our BUY rating and raise our price target to $75.”
According to TipRanks.com, Mills is a top 25 analyst with an average return of 34.9% and a 77.1% success rate. Mills covers the Healthcare sector, focusing on stocks such as Boston Scientific Corp, Staar Surgical Company, and Merit Medical Systems.
Currently, the analyst consensus on Tactile Systems Technology is a Moderate Buy with an average price target of $64.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
